Back

Impact of the SYNTAX score on mortality in older adults treated with percutaneous coronary intervention

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Cardiovascular disease in older adults (3) Cardiovascular Disease in the Elderly ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Ahmet Atil Aygun

Istanbul University Cerrahpasa Faculty of Medicine, Istanbul (Turkiye)

6 More presentations in this session

Presentation thumbnail
Thromboembolic pulmonary hypertension in the elderly: approach in a reference center for an increasing population
Doctor M. Coronel (Corrientes, AR)
Abstract Slides Video
Presentation thumbnail
Four-cardiac chambers remodeling in atrial fibrillation: is there a role for Clonal Hematopoiesis of Indeterminate Potential (CHIP)?
Professor A. Cohen (Paris, FR)
Abstract Slides Video
Presentation thumbnail
The impact of IGF-1 deficiency on cardiometabolic risk factors in the elderly population
Professor A. Zebrowska (Katowice, PL)
Abstract Slides Video
Presentation thumbnail
Plasma neurofilament light as a risk marker cardiovascular disease in healthy elderly
Doctor J. Aulin (Uppsala, SE)
Abstract Slides Video
Presentation thumbnail
Differential impact of frailty on hospital evolution depending on the type of acute coronary syndrome (STEMI vs NSTEACS)
Doctor F. Buendia Santiago (Cartagena, ES)
Abstract Slides Video

Access the full session

Session thumbnail
Cardiovascular disease in older adults (3)

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Prognostic significance of QFR-based SYNTAX score in patients with coronary artery disease: a systematic review and meta-analysis
thumbnail
Congress Presentation
Patient frailty (measured by Hendrich II score) is a strong, independent predictor of mortality in acute coronary syndromes treated with percutaneous coronary intervention
thumbnail
Congress Session
Determinants of outcome following different coronary revascularisation approaches

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources